Clonidine
Sujin Lee Weinstein, PharmD, BCPP
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Attention deficit hyperactivity disorder
(ADHD) in pediatric patients (
>
6 years old), as monotherapy or adjunctive therapy with stimulants
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Post traumatic stress disorder
, Tourette’s syndrome,
insomnia
,
opioid withdrawal symptoms
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.